Oncology : Last 20 articles http://content.karger.com Last 20 articles published in Oncology en Copyright 2009, S.Karger AG Fri, 20 Nov 2009 00:02:17 +0100 S.Karger AG http://content.karger.com/company/help.asp 20 Oncology http://content.karger.com/ProdukteDB/katalogteile/issn/_0030_2414/cover.gif http://content.karger.com Neuroendocrine Carcinomas Arising in Solid-Organ Transplant Recipients: Rare but Aggressive Malignancies http://content.karger.com/produktedb/produkte.asp?doi=260058 http://content.karger.com/produktedb/produkte.asp?doi=260058 Fri, 20 Nov 2009 00:00:00 +0100 Oncology 2009;77:314-317 (DOI:10.1159/000260058) Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease http://content.karger.com/produktedb/produkte.asp?doi=260057 http://content.karger.com/produktedb/produkte.asp?doi=260057 Fri, 20 Nov 2009 00:00:00 +0100 Oncology 2009;77:304-313 (DOI:10.1159/000260057) A Pilot Study for Combination Chemotherapy Using Gemcitabine and S-1 for Advanced Pancreatic Cancer http://content.karger.com/produktedb/produkte.asp?doi=259616 http://content.karger.com/produktedb/produkte.asp?doi=259616 Tue, 17 Nov 2009 00:00:00 +0100 Oncology 2009;77:300-303 (DOI:10.1159/000259616) Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status http://content.karger.com/produktedb/produkte.asp?doi=259615 http://content.karger.com/produktedb/produkte.asp?doi=259615 Tue, 17 Nov 2009 00:00:00 +0100 Oncology 2009;77:293-299 (DOI:10.1159/000259615) Lactate Dehydrogenase 5 Expression in Squamous Cell Head and Neck Cancer Relates to Prognosis following Radical or Postoperative Radiotherapy http://content.karger.com/produktedb/produkte.asp?doi=259260 http://content.karger.com/produktedb/produkte.asp?doi=259260 Mon, 16 Nov 2009 00:00:00 +0100 Oncology 2009;77:285-292 (DOI:10.1159/000259260) Cisplatin and Vinorelbine Chemotherapy in Recurrent Vulvar Carcinoma http://content.karger.com/produktedb/produkte.asp?doi=259259 http://content.karger.com/produktedb/produkte.asp?doi=259259 Mon, 16 Nov 2009 00:00:00 +0100 Oncology 2009;77:281-284 (DOI:10.1159/000259259) The Roles of National Cancer Research Institutions in Evolving a Comprehensive Cancer Control Program in a Developing Country: Experience from Uganda http://content.karger.com/produktedb/produkte.asp?doi=259258 http://content.karger.com/produktedb/produkte.asp?doi=259258 Mon, 16 Nov 2009 00:00:00 +0100 Oncology 2009;77:272-280 (DOI:10.1159/000259258) Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib http://content.karger.com/produktedb/produkte.asp?doi=258880 http://content.karger.com/produktedb/produkte.asp?doi=258880 Mon, 16 Nov 2009 00:00:00 +0100 Oncology 2009;77:257-271 (DOI:10.1159/000258880) Liability of the Voltage-Gated Sodium Channel Gene SCN2A R19K Polymorphism to Oxaliplatin-Induced Peripheral Neuropathy http://content.karger.com/produktedb/produkte.asp?doi=236049 http://content.karger.com/produktedb/produkte.asp?doi=236049 Mon, 07 Sep 2009 00:00:00 +0100 Oncology 2009;77:254-256 (DOI:10.1159/000236049) Costs Associated with Capecitabine or 5-Fluorouracil Monotherapy after Surgical Resection in Patients with Colorectal Cancer http://content.karger.com/produktedb/produkte.asp?doi=236048 http://content.karger.com/produktedb/produkte.asp?doi=236048 Mon, 07 Sep 2009 00:00:00 +0100 Oncology 2009;77:244-253 (DOI:10.1159/000236048) Activation of Sonic Hedgehog Signaling Pathway in Olfactory Neuroblastoma http://content.karger.com/produktedb/produkte.asp?doi=236047 http://content.karger.com/produktedb/produkte.asp?doi=236047 Mon, 07 Sep 2009 00:00:00 +0100 Oncology 2009;77:231-243 (DOI:10.1159/000236047) The Role of KRAS Mutations in Predicting the Efficacy of Cetuximab-Plus-Irinotecan Therapy in Irinotecan-Refractory Korean Metastatic Colorectal Cancer Patients http://content.karger.com/produktedb/produkte.asp?doi=236046 http://content.karger.com/produktedb/produkte.asp?doi=236046 Mon, 07 Sep 2009 00:00:00 +0100 Oncology 2009;77:224-230 (DOI:10.1159/000236046) Erratum http://content.karger.com/produktedb/produkte.asp?doi=237382 http://content.karger.com/produktedb/produkte.asp?doi=237382 Fri, 04 Sep 2009 00:00:00 +0100 Oncology 2009;77:256 (DOI:10.1159/000237382) Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment? http://content.karger.com/produktedb/produkte.asp?doi=236022 http://content.karger.com/produktedb/produkte.asp?doi=236022 Fri, 04 Sep 2009 00:00:00 +0100 Oncology 2009;77:217-223 (DOI:10.1159/000236022) Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology Group http://content.karger.com/produktedb/produkte.asp?doi=236021 http://content.karger.com/produktedb/produkte.asp?doi=236021 Fri, 04 Sep 2009 00:00:00 +0100 Oncology 2009;77:212-216 (DOI:10.1159/000236021) The Utility of Rapid Diagnosis of Lymph Node Metastasis in Gastric Cancer Using a Multiplex Real-Time Reverse Transcription Polymerase Chain Reaction Assay http://content.karger.com/produktedb/produkte.asp?doi=236020 http://content.karger.com/produktedb/produkte.asp?doi=236020 Fri, 04 Sep 2009 00:00:00 +0100 Oncology 2009;77:205-211 (DOI:10.1159/000236020) Imatinib in Gastrointestinal Stromal Tumor: Does Treatment Duration Matter? http://content.karger.com/produktedb/produkte.asp?doi=236019 http://content.karger.com/produktedb/produkte.asp?doi=236019 Fri, 04 Sep 2009 00:00:00 +0100 Oncology 2009;77:157-161 (DOI:10.1159/000236019) Macroscopic Borrmann Type as a Simple Prognostic Indicator in Patients with Advanced Gastric Cancer http://content.karger.com/produktedb/produkte.asp?doi=236018 http://content.karger.com/produktedb/produkte.asp?doi=236018 Thu, 03 Sep 2009 00:00:00 +0100 Oncology 2009;77:197-204 (DOI:10.1159/000236018) Phase II Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Colorectal Cancer http://content.karger.com/produktedb/produkte.asp?doi=236017 http://content.karger.com/produktedb/produkte.asp?doi=236017 Thu, 03 Sep 2009 00:00:00 +0100 Oncology 2009;77:192-196 (DOI:10.1159/000236017) Effect of Low-Dose Paclitaxel and Docetaxel on Endothelial Progenitor Cells http://content.karger.com/produktedb/produkte.asp?doi=236016 http://content.karger.com/produktedb/produkte.asp?doi=236016 Thu, 03 Sep 2009 00:00:00 +0100 Oncology 2009;77:182-191 (DOI:10.1159/000236016)